TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Treasury Shares (2025 - 2026)

Updated

TScan Therapeutics (TCRX) reported Treasury Shares of 92.65 million for Q2 2026, down 99.9% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Treasury Shares (2025 - 2026) Analysis & Trends

At the end of FY2025, TScan Therapeutics posted Treasury Shares of 97.76 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 712.73 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 77.07 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.11 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92.65 Mn
Mar 31, 2026 100.33 Bn
Dec 31, 2025 97.76 Mn
API Access

TScan Therapeutics Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=TCRX&period=max&api_key=YOUR_API_KEY